RG (@raygachette) header
RG (@raygachette) profile picture

🇩🇴 PharmD / Trader 💊 Avid sports fan 🏈 40+ Twitter 📈 Not investment advice 📊 Discipline trumps conviction ⚠️ Be transformed by the renewal of your mind™️

Jackson Heights, New York
Joined November 2012
Photo by RG (@raygachette)Photo by RG (@raygachette)Photo by RG (@raygachette)Photo by RG (@raygachette)Photo by RG (@raygachette)Photo by RG (@raygachette)Photo by RG (@raygachette)Photo by RG (@raygachette)Photo by RG (@raygachette)Photo by RG (@raygachette)
Contributing factor why $NVDA likely stays range bound for the foreseeable future
2
81
$TGT | Target Q3 2026 Earnings - Net Sales: $27.07B (est $26.53B) - Adj EPS: $2.65 (est $2.08) - Gross Margin: 30.5% vs 28.2% Y/Y - Sees FY Net Sales Growth: Around 6% - Sees FY Oper Income Margin Rate: Around 6.2% - Sees FY Adj EPS: $10.65 To $11.40 (prev $9.90 To $10.90)
2
6
1
11
13,447
1/ Options priced about an 8% move in $NVDA after results. It moved 4.8% after hours, to $162.95. One-month implied vol closed at 63.1%, the highest of the past year and 10.3 points above realized. That premium is what drains today.
6
7
1
24
6,815
$NVDA | Nvidia Q3 27 Earnings: • Rev: $115.8B (est $109.33B) • Adj EPS: $2.68 (est $2.47) • Data Centre Rev: $107.6B (est $101.87B) • Compute & Networking Rev: $106.0B (est $98.27B) • Edge Computing Rev: $8.2B (est $7.5B) • Graphics Rev: $9.8B (est $8.84B) • Sees Q4 Rev: $127.4B To $132.6B (est $125.25B) • Sees Q4 Adj Gross Margin: 71% To 72% • Sees Q4 Adj Oper Expenses: Around $10.7B (est $9.99B) • Board Approves Additional $150B Share Buyback In Sep
2
14
2
37
17,069
API Inventory Moves 11/17 Crude +5.3 million Gasoline +5.1 million Distillates +400,000 Cushing -1.691 million SPR actual -3.1 million #oott #crudeoil #gasoline #distillates #SPR #API
10
25
7
142
26,414
Didn’t pick up a coffee before the drive to work and already regretting the decision
1
49
A sign of the times
5 MAJOR DISRUPTIONS IN JUST 6 DAYS 🇺🇸 Nov 17: NSA classified network DOWN 🏦 Nov 16: JPMorgan banking failure ✈️ Nov 16: United Airlines outage 🛑 Nov 13: FAA nationwide ground stop 🌐 Nov 12–13: Microsoft 365 outage No coordinated cyberattack confirmed.
47
$SLS +300% (Market cap: ~$6B) Sellas Life Sciences' experimental cancer vaccine extended survival in a pivotal Phase 3 leukemia trial, meeting its primary endpoint. Its vaccine, galinpepimut-S (GPS), reduced the risk of death by 41% compared with the best available treatment in patients with acute myeloid leukemia (AML), with a statistically significant hazard ratio of 0.59 (p=0.035). Median overall survival: • GPS vaccine: 24.0 months • Best available treatment: 14.7 months That's a 9.3-month improvement in median survival. The 126-patient REGAL trial focused on AML patients in their second or later remission who were unable to undergo a stem cell transplant, a group with limited treatment options. Licensed from Memorial Sloan Kettering, GPS is designed to stimulate the immune system to target residual leukemia cells expressing the WT1 protein. The vaccine was generally well tolerated, with mostly mild to moderate side effects, primarily injection-site reactions. No new safety concerns were identified. Sellas now plans to meet with the FDA to discuss an accelerated filing strategy, targeting a submission for approval in the first half of 2027. Full secondary endpoint results are still pending, and the vaccine remains investigational.
11
33
9
247
57,245
$DIS | Disney Q4 2026 Earnings - Adj EPS: $1.77 (est $1.66) - Rev: $25.95B (est $25.18B) - Sees FY27 Capex: About $9B (est $8.87B) - Sees Q1 FY27 Total Segment Oper Income: About $5.4B - Declares Cash Dividend Of $2.00/Share, To Be Paid In Two Instalments Of $1.00/Share
2
2
11
13,528
US LNG flows hit a record 21.8 Bcf in a single day, up 12% year on year. With Qatari exports disrupted by the Iran war, US suppliers are ramping up to serve Europe and Asia. The LNG supply gap is reshaping global trade flows and tanker demand.
1
1
1
22
4,006
Earnings on deck
Earnings, Economic numbers and IPO $ANT for week of 11/16/26
1
36
ELI LILLY $LLY TO ACQUIRE CALYTRIX BIO FOR UP TO $1.5 BILLION IN CASH The deal includes an upfront payment and additional payments tied to clinical and regulatory milestones. The upfront amount was not disclosed. Calytrix is developing an experimental antibody targeting mutant calreticulin (mCALR), a genetic driver of two blood cancers, essential thrombocythemia and myelofibrosis. Unlike existing treatments that primarily manage symptoms, its lead therapy is designed to target the cells driving the disease while preserving healthy tissue. Calytrix was founded just last year by J.P. Morgan Life Sciences Private Capital, with financing backed by Westlake BioPartners and Avoro Ventures.
6
19
6
163
42,954
$TSN | Tyson Q4 2026 Earnings - Adj EPS: 61c (est 53c) - Sales: $14.59B (est $14.32B) - Loss/Share: 22c vs EPS 13c Y/Y - Sees 27 Sales: -3.5% To -5.5% - Sees 27 Capex: $1.1B To $1.4B (est $965.2M) - Sees 27 Adj Oper Income: $1.7B To $2.15B
4
3
7
14,962
BREAKING: For the first time in >2 months, US average diesel retail prices have fallen below $6 a gallon. At a nationwide average of $5.9989 a gallon, diesel is down now ~8% from its peak in late September, but remains nearly 60% more expensive than a year ago.
27
86
15
629
93,825
US LNG exports rose to a fresh record on new production, a trend that could provide relief to global gas markets rattled by the Hormuz closure 🇺🇸🚢📈 Pipeline gas deliveries to US LNG export plants rose to 21.8 bcf/day, up 12% from a year ago And exports are set to keep rising
12
66
18
211
33,661
Rise & Grind
44
B A N G ‼️
JALEN BRUNSON AHHHHHHHHHHHHHHHHHHHHHHHH
35
Here for the ‘Food Bazaar’ logo on the MSG court during St John’s basketball games. It gives big “Queens Get The Money” Energy
36